Ralf Uebelhack
Overview
Explore the profile of Ralf Uebelhack including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
295
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rasinkangas P, Forssten S, Marttinen M, Ibarra A, Bothe G, Junnila J, et al.
Am J Clin Nutr
. 2022 Sep;
116(6):1580-1594.
PMID: 36149331
Background: Probiotics may alleviate lactose maldigestion. Objectives: The objective was to select a probiotic with high lactase activity and compare it with lactase and placebo in clinical trials. Methods: Bacterial...
2.
Bongartz U, Hochmann U, Grube B, Uebelhack R, Alt F, Erlenbeck C, et al.
Obes Facts
. 2022 Feb;
15(3):395-404.
PMID: 35130547
Introduction: The aim of this study was to evaluate the benefit and tolerability of two dosages of a proprietary flaxseed mucilage (IQP-LU-104) in reducing body weight in overweight and moderately...
3.
Bongartz U, Hochmann U, Pohl U, Bothe G, De Costa P, Chong P, et al.
Exp Ther Med
. 2021 Jan;
21(2):144.
PMID: 33456511
Intense and prolonged exercise leads to immune suppression, causing upper respiratory tract infections (URTI). A proprietary standardized dietary supplement, IQP-AS-119 has been previously developed to aid immune responses under such...
4.
Gruenwald J, Bongartz U, Bothe G, Uebelhack R
Exp Ther Med
. 2020 Feb;
19(2):1490-1499.
PMID: 32010328
Cardiovascular diseases are the main cause of death in the industrialized world, with the main risk factors being elevated blood pressure and blood lipid levels, leading to arterial stiffness and...
5.
More M, Postrach E, Bothe G, Heinritz S, Uebelhack R
Nutrients
. 2019 Dec;
12(1).
PMID: 31881808
The disaccharide and innovative ingredient cellobiose, consisting of two -glucose molecules linked by a (1→4) bond is the main component of cellulose. Cellobiose can be used within a wide variety...
6.
Uebelhack R, Bongartz U, Seibt S, Bothe G, Chong P, De Costa P, et al.
J Obes
. 2019 Aug;
2019:6189724.
PMID: 31380115
[This corrects the article DOI: 10.1155/2019/3412952.].
7.
Bongartz U, Tan B, Seibt S, Bothe G, Uebelhack R, Chong P, et al.
Evid Based Complement Alternat Med
. 2019 Jun;
2019:9178218.
PMID: 31186669
Objective: The purpose of this study was to explore the clinical benefit and tolerability of IQP-AO-101 in healthy subjects with sleep complaints. Methods: This double-blind, randomized, placebo-controlled trial involved fifty...
8.
Gruenwald J, Uebelhack R, More M
Phytomedicine
. 2019 May;
60:152958.
PMID: 31138475
Background: The successful use of rose hip for the treatment of osteoarthritis is well documented. Several randomized placebo controlled double-blind studies, as mono or combination therapy, have demonstrated treatment efficacy...
9.
Uebelhack R, Bongartz U, Seibt S, Bothe G, Chong P, De Costa P, et al.
J Obes
. 2019 Mar;
2019:3412952.
PMID: 30863632
Objective: This study was performed to determine the efficacy and tolerability/safety of IQP-AE-103 on body weight reduction in overweight to moderately obese adults. Methods: A double-blind, randomized, placebo-controlled trial involved...
10.
More M, Gruenwald J, Pohl U, Uebelhack R
Planta Med
. 2017 Jun;
83(18):1384-1391.
PMID: 28614869
The special formulation MA212 (Rosaxan) is composed of rosehip ( L.) puree/juice concentrate, nettle ( L.) leaf extract, and devil's claw ( DC. ex Meisn. or Decne.) root extract and...